Smiths Group PLC
06 July 2005
Smiths Group: Management Change in Medical Division
Smiths Group plc announces the following management change:
Lawrence Kinet, Group Managing Director - Medical, steps down from that role
today and assumes personal responsibility for the international marketing of the
Smiths Medical diabetes product range. Mr Kinet leaves the Smiths Board with
immediate effect.
Einar Lindh, who retired from the Smiths Board in January 2005, rejoins the
company to lead Smiths Medical on an interim basis. Mr Lindh, whose
distinguished career with Smiths included 12 years in senior roles within the
Medical division, will report to Keith Butler-Wheelhouse, Chief Executive of
Smiths Group.
Mr Butler-Wheelhouse said: 'Lawrence has expressed a wish, as he approaches his
planned retirement from Smiths, to concentrate on the 'Cozmo' product range
which he was instrumental in launching. I am pleased that we are able to
respond with this organisational change.
'The search for Lawrence's successor is already under way. Meanwhile we are
very fortunate to have Einar Lindh available to us. Einar's track record at
Smiths Group, latterly as head of the Specialty Engineering division, is well
known and his past experience within Medical will be invaluable. I look forward
to working with Einar to secure the full potential of our Medical business.'
The company will issue its normal year end trading statement in early August
2005.
-o-
Media: Investors:
Chris Fox Russell Plumley
+44 (0) 20 8457 8403 +44 (0) 20 8457 8203
chris.fox@smiths-group.com russell.plumley@smiths-group.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.